Verpooten GA - Search Results

1

Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.

Tielemans CL, Vlasak J, Kosa D, Billiouw JM, Verpooten GA, Mezei I, Ryba M, Peeters PC, Mat O, Jadoul MY, Polakovic V, Dhaene M, Treille S, Kuriyakose SO, Leyssen M, Houard SA, Surquin M. Tielemans CL, et al. Among authors: verpooten ga. Vaccine. 2011 Feb 1;29(6):1159-66. doi: 10.1016/j.vaccine.2010.12.009. Epub 2010 Dec 16. Vaccine. 2011. PMID: 21167859 Clinical Trial.

2

Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients.

Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME. Lefebure AF, et al. Among authors: verpooten ga. Vaccine. 1993;11(4):397-9. doi: 10.1016/0264-410x(93)90278-6. Vaccine. 1993. PMID: 8470423 Clinical Trial.

3

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.

Lins RL, Matthys KE, Billiouw JM, Dratwa M, Dupont P, Lameire NH, Peeters PC, Stolear JC, Tielemans C, Maes B, Verpooten GA, Ducobu J, Carpentier YA. Lins RL, et al. Among authors: verpooten ga. Clin Nephrol. 2004 Oct;62(4):287-94. doi: 10.5414/cnp62287. Clin Nephrol. 2004. PMID: 15524059 Clinical Trial.

4

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients.

Lins RL, Matthys KE, Verpooten GA, Peeters PC, Dratwa M, Stolear JC, Lameire NH. Lins RL, et al. Among authors: verpooten ga. Nephrol Dial Transplant. 2003 May;18(5):967-76. doi: 10.1093/ndt/gfg048. Nephrol Dial Transplant. 2003. PMID: 12686673 Clinical Trial.

5

Legionella pneumophila peritonitis in a kidney transplant patient.

Arnouts PJ, Ramael MR, Ysebaert DK, Verpooten GA, de Broe ME, van Marck EA, Pattyn SR. Arnouts PJ, et al. Among authors: verpooten ga. Scand J Infect Dis. 1991;23(1):119-22. doi: 10.3109/00365549109023386. Scand J Infect Dis. 1991. PMID: 2028225

6

Aminoglycoside nephrotoxicity: mechanism and prevention.

De Broe ME, Giuliano RA, Verpooten GA. De Broe ME, et al. Among authors: verpooten ga. Adv Exp Med Biol. 1989;252:233-45. doi: 10.1007/978-1-4684-8953-8_22. Adv Exp Med Biol. 1989. PMID: 2675552 Review. No abstract available.

7

Functional acute renal failure in a patient with carcinoid syndrome.

Couttenye MM, Verpooten GA, Daelemans RA, De Broe ME. Couttenye MM, et al. Among authors: verpooten ga. Nephron. 1987;47(2):131-3. doi: 10.1159/000184475. Nephron. 1987. PMID: 3696318

8

Determination of ionized calcium: evaluation of sampling and storage procedures.

Couttenye MM, Jurgens A, Lamberts LV, Verpooten GA, D'Haese PC, De Broe ME. Couttenye MM, et al. Among authors: verpooten ga. Clin Chem. 1996 Mar;42(3):468-9. Clin Chem. 1996. PMID: 8598117 No abstract available.

9

Pharmacokinetics of neoral before and after total gastrectomy in a renal transplant patient.

Chapelle T, Roeyen G, De Greef K, Verpooten GA, Bosmans JL, Martin M, De Broe ME, Ysebaert DK. Chapelle T, et al. Among authors: verpooten ga. Transplant Proc. 2002 May;34(3):805-6. doi: 10.1016/s0041-1345(01)02917-7. Transplant Proc. 2002. PMID: 12034189 No abstract available.

10

Laser microprobe mass spectrometric identification of cyclosporin-induced intrarenal microliths in rat.

Verbueken AH, Van Grieken RE, Verpooten GA, De Broe ME, Wedeen RP. Verbueken AH, et al. Among authors: verpooten ga. Biol Mass Spectrom. 1992 Nov;21(11):590-6. doi: 10.1002/bms.1200211111. Biol Mass Spectrom. 1992. PMID: 1457472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters